Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Gilead Sciences, Inc.

Where
Hybrid in United States - California - El Segundo
Pay
$206K a year

Posted 16 days ago· Checked live at Gilead Sciences, Inc. 4 days ago

Live.Open on the employer's own site.

See how you score for this job

One sentence and your resume. We score it against what Gilead Sciences, Inc. asks for, line by line.

See my score
Is this job still open?
Yes. We checked it live on Gilead Sciences, Inc.'s own hiring page 4 days ago.
What is the job?
We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.
What does it pay?
$206K a year, as the posting states.
Our verdict
Live. Open on the employer's own site.

What the job is

We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.

Basic Qualifications

8+ years with a PhD/ PharmD

OR

10+ years with MS/MA, MBA, PharmD, PhD or equivalent advanced degree

OR

12+ years with BS/BA

Preferred Qualifications

  • 3+ years of direct experience supporting autoimmune disease programs, including development-stage assets, clinical strategy, market access, medical affairs, commercial strategy, or related functions.
  • Deep understanding of autoimmune disease treatment paradigms, competitive dynamics, and unmet patient needs.
  • Experience in advanced therapies, including cell therapy and/or gene therapy, strongly preferred.
  • Experience supporting market access, pricing, reimbursement, HEOR, commercial strategy, or related functions within the pharmaceutical or biotechnology industry.
  • Experience supporting early and/or late-stage development programs and translating payer insights into development decisions.
  • Demonstrated experience incorporating payer, HTA, and health system requirements into clinical development and evidence generation strategies.
  • Experience supporting launch readiness activities, global launch planning, and lifecycle management.
  • Strong understanding of global payer, pricing, reimbursement, and HTA landscapes.
  • Experience partnering with HEOR, RWE, Medical Affairs, Clinical Development, and Commercial functions to develop value evidence strategies.
  • Understanding of value frameworks, reimbursement pathways, and evidence requirements across major global markets.
  • Demonstrated ability to influence cross-functional teams in a matrix environment.
  • Strong strategic thinking, analytical, and problem-solving skills.
  • Excellent communication skills and experience presenting to senior leadership.
  • Proven ability to collaborate across functions, regions, cultures, and time zones.
  • Ability to thrive in a fast-paced environment characterized by innovation and portfolio growth.

The salary range for this position is

Other US Locations: $205,615.00 - $266,090.00.

Bay Area: $226,185.00 - $292,710.00.

Kite considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.

For additional benefits information, visit

https://www.gilead.com/careers/compensation-benefits-and-wellbeing

  • Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.